Profile
DHR-PA DHR-PB TMO DHR IQV A
Company Name Danaher Corporation Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IQVIA Holdings Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap - $916.76B $231.76B $197.82B $43.69B $40.06B
Employees 78.00K 79.00K 122.00K 61.00K 88.00K 17.60K
CEO - Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Ari Bousbib Mr. Padraig McDonnell
Ratings
DHR-PA DHR-PB TMO DHR IQV A
Quant Rating Score 5 5 3 3 3 3
Quant Rating Strong Buy Strong Buy Neutral Neutral Neutral Neutral
Trading
DHR-PA DHR-PB TMO DHR IQV A
Last Close $1841.01 $1261.26 $607.14 $273.91 $239.67 $137.32
High 52 $1841.01 $1261.26 $607.14 $273.91 $259.1 $154.64
Low 52 $1841.01 $1261.26 $431.41 $185.1 $177.16 $101.17
Price vs. 52 Week High 0 % 0 % 0 % 0 % -7.5 % -11.2 %
Price vs. 52 Week Low 0 % 0 % 40.73 % 47.98 % 35.28 % 35.73 %
Total Return
DHR-PA DHR-PB TMO DHR IQV A
1 Month Return 0 % 0 % 10.23 % 8.8 % 12.65 % 4.98 %
3 Month Return 0 % 0 % 5.85 % 11.08 % 2.04 % -0.3 %
6 Month Return 0 % 0 % 10.93 % 17.56 % 10.91 % 4.83 %
9 Month Return 0 % 0 % 40.73 % 45.79 % 33.19 % 33.62 %
YTD Return 0 % 0 % 14.38 % 18.4 % 3.58 % -1.23 %
1 Year Return 0 % 0 % 8.41 % 7.3 % 6.73 % 8.42 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DHR-PA DHR-PB TMO DHR IQV A
Dividend Yield Percentage (TTM) 0.38 % 0.38 % 0.24 % 0.38 % - 0.68 %
Dividend Paid and Capex Coverage Ration (TTM) 4.11 % 3.16 % 4.82 % 2.53 % 3.98 % 3.02 %
Dividend Per Share (TTM) 1.05 % 1.05 % 1.48 % 1.05 % - 0.93 %
Payout Ratio (TTM) 11.69 % 17.87 % 8.91 % 28.62 % - 21.74 %
Growth
DHR-PA DHR-PB TMO DHR IQV A
Asset Growth 0.16 % 0.16 % 1.62 % 0.16 % 5.3 % 2.35 %
Gross Profit Growth -25.94 % -25.94 % -21.93 % -25.94 % -17.76 % -6.9 %
Revenue Growth -24.09 % -24.09 % -4.58 % -24.09 % 4.13 % -0.22 %
Revenue 3 Year 2.8 % 2.8 % 36.47 % 2.8 % 37.49 % 34.51 %
Revenue 5 Year 14.24 % 14.24 % 83.24 % 14.24 % 59.72 % 51.82 %
Revenue 10 Year 18.09 % 18.09 % 205.6 % 18.09 % 98.74 % 16.86 %
EBIT Growth -40.12 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Net Income Growth -33.92 % -33.92 % -13.74 % -33.92 % 24.47 % -1.12 %
Net Income 3 Yeari Growth Per Share 25.29 % 25.29 % -3.52 % 25.29 % 406.6 % 81.26 %
Net Income 5 Yeari Growth Per Share 70.95 % 70.95 % 112.51 % 70.95 % 481.09 % 328.44 %
Net Income 10 Yeari Growth Per Share 67.05 % 67.05 % 339.48 % 67.05 % 304.81 % 98.65 %
Operating Income Growth -40.12 % -40.12 % -12.81 % -40.12 % 15.73 % -16.56 %
Operating Cash Flow Growth (CFG) -15.91 % -15.91 % -8.17 % -15.91 % -4.91 % 35.06 %
Operating 3 Year CFG 10.65 % 10.65 % 4.04 % 10.65 % 14.18 % 102.22 %
Operating 5 Year CFG 69.44 % 69.44 % 92.7 % 69.44 % 89.93 % 77.99 %
Operating 10 Year CFG 88.83 % 88.83 % 290.23 % 88.83 % 265.29 % 78.41 %
EPS Growth -34.29 % -34.29 % -12.41 % -34.29 % 26.98 % 0.72 %
EPS Diluted Growth -33.82 % -33.82 % -12.41 % -33.82 % 27.45 % 0.24 %
Book Value Per Share 5.14 % 5.14 % 7.9 % 5.14 % 8.21 % 12.39 %
Share Holder 3 Year Equity Growth Per Share 28.97 % 28.97 % 38.91 % 28.97 % 6.01 % 26.07 %
Share Holder 5 Year Equity Growth Per Share 80.33 % 80.33 % 76.4 % 80.33 % 0.89 % 39.74 %
Share Holder 10 Year Equity Growth Per Share 125.79 % 125.79 % 158.74 % 125.79 % 718.56 % 28.25 %
Dividend Per Share Growth 50.21 % 50.21 % 16.73 % 50.21 % - 7.8 %
Dividend 3 Year Growth Per Share 94.58 % 94.58 % 59.21 % 94.58 % - 25.46 %
Dividend 5 Year Growth Per Share 173.92 % 173.92 % 104.77 % 173.92 % - 51.49 %
Dividend 10 Year Growth Per Share 2163.67 % 2163.67 % 125.8 % 2163.67 % - 97.03 %
Debt Growth -0.72 % -0.72 % 1.24 % -0.72 % 9.38 % -1.23 %
Free Cash Flow Growth -21.53 % -21.53 % 0.23 % -21.53 % -5.42 % 44.37 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023
Profitability
DHR-PA DHR-PB TMO DHR IQV A
Gross Profit Margin TTM 60.95 % 58.45 % 40.3 % 59.41 % 29.7 % 50.71 %
Return on Assets TTM 7.63 % 5.33 % 6.33 % 5.35 % 5.39 % 11.44 %
Return on Equity TTM 14.95 % 8.42 % 13.48 % 8.04 % 22.79 % 20.87 %
Return on Capital Employed TTM 10.56 % 7.39 % 8.76 % 6.21 % 10.68 % 14.65 %
Net Income Per EBT TTM 83.54 % 83.98 % 90.86 % 99.88 % 94.99 % 93.45 %
EBT Per Ebit TTM 95.91 % 94.74 % 93.52 % 94.37 % 70.93 % 101.92 %
EBIT Per Revenue TTM 26.9 % 21.3 % 17.32 % 21.13 % 13.9 % 19.78 %
Cash Flow To Debt Ratio TTM 35.91 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Receivables Turnover TTM 6.36 7.76 5.33 6.4 4.61 5.28
Payables Turnover TTM 4.48 6.49 - 5.21 3.23 7.05
Inventory Turnover TTM 4.16 4.12 4.86 3.21 - 3.25
Fixed Asset Turnover TTM 777.12 % 463.28 % 456.22 % 367.49 % 1979.04 % 429.94 %
Asset Turnover TTM 35.41 % 31.45 % 42.99 % 26.87 % 57.58 % 60.71 %
Operating Cash Flow Per Share TTM 90.87 9.27 24.47 8.74 13.39 6.47
Free Cash Flow Per Share TTM 76.8 7.39 20.85 6.92 10.03 5.25
Cash Per Share TTM 2811.52 % 937.04 % 2309.69 % 321.85 % 920.97 % 570.31 %
Operating Cash Flow Sales Ratio TTM 28.38 % 26.52 % 22.08 % 30.55 % 16.05 % 28.77 %
Free Cash Flow Operating Cash Flow Ratio TTM 84.52 % 79.76 % 85.18 % 79.14 % 74.88 % 81.12 %
Cash Flow Coverage Ratios TTM 35.91 % 36.11 % 26.4 % 35.4 % 18.4 % 69.55 %
Price To Free Cash Flows Ratio TTM 28 35.66 29.1 38.77 23.91 26.05
Price To Operating Cash Flows Ratio TTM 3.01 29.55 24.81 31.34 17.9 21.22
Price Cash Flow Ratio TTM 3.01 29.55 24.81 31.34 17.9 21.22
Income Statement (TTM)
DHR-PA DHR-PB TMO DHR IQV A
Revenue $23.89B $23.89B $42.86B $23.89B $15.01B $6.83B
Gross Profit $14.03B $14.03B $15.22B $14.03B $4.14B $3.47B
Gross Profit Ratio 58.74% 58.74% 35.52% 58.74% 27.56% 50.71%
EBITDA $7.76B $7.76B $10.72B $7.76B $3.21B $1.71B
Net Income $4.76B $4.76B $6B $4.76B $1.36B $1.24B
EPS Diluted 6.38 6.38 15.45 6.38 7.29 4.19
Balance Sheet (MRQ)
DHR-PA DHR-PB TMO DHR IQV A
Long Term Debt $17.66B $17.66B $31.31B $17.66B $12.96B $2.74B
Total Liabilities $31B $31B $51.88B $31B $20.57B $4.92B
Total Equity $53.49B $53.49B $46.84B $53.49B $6.11B $5.85B
Total Investments $0.01B $0.01B $-1.92B $0.01B $0.36B $0.16B
Total Debt $19.54B $19.54B $34.92B $19.54B $14.23B $2.74B
Total Assets $84.49B $84.49B $98.73B $84.49B $26.68B $10.76B
Cash Flow Statement (TTM)
DHR-PA DHR-PB TMO DHR IQV A
Net Income $4.22B $4.22B $6B $4.22B $1.36B $1.24B
Inventory $0.19B $0.19B $0.6B $0.19B $0B $-0.03B
Dividends Paid $-1.25B $-1.25B $-0.52B $-1.25B $0B $-0.27B
Operating Cash Flow $7.16B $7.16B $8.41B $7.16B $2.15B $1.77B
Capital Expenditure $-1.38B $-1.38B $-1.48B $-1.38B $-0.65B $-0.3B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 137.32
ACRS Aclaris Therapeutics, Inc. 1.39
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.4101
AWH Aspira Women's Health Inc. 1.49
BDSX Biodesix, Inc. 1.72
BIAF bioAffinity Technologies, Inc. 2.71
BIAFW bioAffinity Technologies, Inc. 0.55
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 0.627
BNR Burning Rock Biotech Limited 6.38
CDNA CareDx, Inc 19.01
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.01
CNTG Centogene N.V. 0.34
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 233.47
CSTL Castle Biosciences, Inc. 21.06
DGX Quest Diagnostics Incorporated 145.59
DHR Danaher Corporation 273.91
Unlock